All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.
During the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the MDS Hub was pleased to speak to Nil Albiol, Hospital de la Santa Creu i Sant Pau, Barcelona, ES. We asked, Do mRNA-based COVID vaccines lead to adverse events in recently transplanted patients?
Do mRNA-based COVID vaccines lead to adverse events in recently transplanted patients?
In this video, Albiol discusses the initial exclusion of transplanted patients from COVID vaccine trials due to the risk of immune-mediated complications. Albiol then comments on the study performed at his center and two other recently published studies, which did not find these side effects in transplanted patients. Finally, Albiol compares the overall results in transplanted patients to the general population.
NCCN COVID-19 vaccination recommendations for patients with hematologic malignancies
Patients with cancer are at high risk of COVID-19-associated complications and, accordingly, the preliminary recommendations issued by the National Comprehensive...
How does COVID-19 infection affect hematopoiesis in MDS?
During the ESH 2nd Translational Research Conference: Erythropoiesis Control and Ineffective Erythropoiesis - From Bench to Bedside, the MDS Hub spoke to Eric Solary, Gustave Roussy, Paris, FR....
Subscribe to get the best content related to MDS delivered to your inbox